HLB Co., Ltd.
028300
Classificação em ações
#3919
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Preço da ação
$31.27
Valor de mercado
$4.16B
Variação (1 dia)
6.78%
Variação (1 ano)
1.26%
País
KR
Negociar HLB Co., Ltd. (028300)
Categoria
Healthcare
Receita da HLB Co., Ltd. (028300)
Receita em Jun 2026 TTM: $67.40M
De acordo com os últimos relatórios financeiros da HLB Co., Ltd., a receita atual da empresa (TTM) é $67.40M. Em 2024, a empresa obteve uma receita de $46.34M um aumento em relação a a receita do ano 2023, que foi de $33.14M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da HLB Co., Ltd. de 2005 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $67.40M | 16.03% |
| 2025 | $58.08M | 25.35% |
| 2024 | $46.34M | 39.83% |
| 2023 | $33.14M | -76.73% |
| 2022 | $142.41M | 142.47% |
| 2021 | $58.73M | 13.50% |
| 2020 | $51.75M | 55.52% |
| 2019 | $33.27M | 2.38% |
| 2018 | $32.50M | 50.54% |
| 2017 | $21.59M | -13.64% |
| 2016 | $25.00M | -23.62% |
| 2015 | $32.73M | -3.69% |
| 2014 | $33.98M | 71.94% |
| 2013 | $19.76M | -59.26% |
| 2012 | $48.51M | -19.12% |
| 2011 | $59.98M | 50.15% |
| 2010 | $39.95M | 55.50% |
| 2009 | $25.69M | 826.29% |
| 2008 | $2.77M | -48.91% |
| 2007 | $5.43M | -45.59% |
| 2006 | $9.98M | 53.88% |
| 2005 | $6.48M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $12.62B | 18,631.01% |
US
|
|
| $2.23B | 3,205.74% |
US
|
|
| $15.74B | 23,260.28% |
AU
|
|
| $6.02B | 8,833.94% |
NL
|
|
| - | - |
CH
|
